Latest News

Promising chronic pain drug developed

A recent report indicates that 116-million Americans live with some form of chronic pain. Historically, chemists have developed drugs aimed at just one biological target. Two drugs used together may metabolize differently or present other issues. This new drug, named UMB 425 affects two different opioid receptors, providing diminished tolerance.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Stereotypes lower math performance in women, but effects go unrecognized

  • For drivers with telescopic lenses, driving experience and training affect road test results

  • Will you ever pay off your student loan?

  • Public Health Responsibility Deal in UK unlikely to be an effective response to alcohol harms

  • Immunotherapy used to reduce memory problems with Alzheimer's disease

  • How the brain 'remembers' pain

  • Calcium channels play a role in neuronal homeostasis, elimination of toxic buildup of proteins

  • Love the cook, love the food: Attraction to comfort food linked to positive social connections

  • Intergenerational transmission of abuse and neglect more complicated than previously believed

  • Researchers identify timeline for HIV replication in the brain

  •